This company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsAgatos（5JS1）株式概要Operates as an engineering, procurement, and construction company in Italy. 詳細5JS1 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長5/6過去の実績0/6財務の健全性0/6配当金0/6報酬収益は年間129.43%増加すると予測されています リスク分析意味のある時価総額がありません ( €5M )マイナスの株主資本 過去1年間で株主の希薄化は大幅に進んだ 株式の流動性は非常に低い すべてのリスクチェックを見る5JS1 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€0.2290.5% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-13m101m2016201920222025202620282031Revenue €101.1mEarnings €5.5mAdvancedSet Fair ValueView all narrativesAgatos S.p.A. 競合他社AHT Syngas TechnologySymbol: DB:3SQ1Market cap: €7.2mPittler MaschinenfabrikSymbol: DB:PITMarket cap: €4.1mBAUERSymbol: HMSE:B5A0Market cap: €250.5mCompleo Charging SolutionsSymbol: XTRA:C0MMarket cap: €14.3m価格と性能株価の高値、安値、推移の概要Agatos過去の株価現在の株価€0.2252週高値€0.7152週安値€0.16ベータ1.131ヶ月の変化0%3ヶ月変化-2.22%1年変化-58.96%3年間の変化-78.11%5年間の変化n/aIPOからの変化-80.87%最新ニュースNew Risk • Jul 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-€3.4m). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Market cap is less than US$10m (€8.25m market cap, or US$9.18m). Minor Risk Less than 1 year of cash runway based on current free cash flow (-€7.9m).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Sep 24Agatos S.p.A. announced that it expects to receive €10 million in funding from Macquarie Group Limited, Investment Arm and other investorAgatos S.p.A. announced a private placement of convertible bonds for gross proceeds of up to €10,000,000 on September 22, 2022. The transaction will include participation from Macquarie Group Limited, Investment Arm, and ATLAS CAPITAL. The company has approved partial issuance of first tranche of convertible bond for up to €1,500,000.Reported Earnings • Jun 18Full year 2021 earnings releasedFull year 2021 results: Net loss: €13.2m (loss widened 247% from FY 2020).Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Oct 06First half 2021 earnings releasedThe company reported a soft first half result with increased losses and weaker control over costs, although revenues improved. First half 2021 results: Revenue: €1.93m (up 17% from 1H 2020). Net loss: €6.82m (loss widened 366% from 1H 2020).最新情報をもっと見るRecent updatesNew Risk • Jul 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-€3.4m). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Market cap is less than US$10m (€8.25m market cap, or US$9.18m). Minor Risk Less than 1 year of cash runway based on current free cash flow (-€7.9m).Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.お知らせ • Sep 24Agatos S.p.A. announced that it expects to receive €10 million in funding from Macquarie Group Limited, Investment Arm and other investorAgatos S.p.A. announced a private placement of convertible bonds for gross proceeds of up to €10,000,000 on September 22, 2022. The transaction will include participation from Macquarie Group Limited, Investment Arm, and ATLAS CAPITAL. The company has approved partial issuance of first tranche of convertible bond for up to €1,500,000.Reported Earnings • Jun 18Full year 2021 earnings releasedFull year 2021 results: Net loss: €13.2m (loss widened 247% from FY 2020).Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.Reported Earnings • Oct 06First half 2021 earnings releasedThe company reported a soft first half result with increased losses and weaker control over costs, although revenues improved. First half 2021 results: Revenue: €1.93m (up 17% from 1H 2020). Net loss: €6.82m (loss widened 366% from 1H 2020).Breakeven Date Change • Sep 23Forecast to breakeven in 2022The analyst covering Agatos expects the company to break even for the first time. New forecast suggests the company will make a profit of €1.72m in 2022. Average annual earnings growth of 99% is required to achieve expected profit on schedule.お知らせ • Dec 30Sorgenia Sviluppo S.R.L. completed the acquisition of 75% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. (BIT:AGA) for €3.1 million.Sorgenia Sviluppo S.R.L. made a binding offer to acquire 80% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. (BIT:AGA) for €2.2 million on October 10, 2019. On December 17, 2020, Sorgenia Sviluppo S.R.L. signed agreement to acquire 75% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. Under the terms, the buyer will pay up to €0.2 million and will take up to 80% of Agatos's claims towards the project for up to €2 million. As of April 21, 2020, Agatos said that more time is needed to complete the transaction amid COVID-19 crisis. As of July 8, 2020, Agatos S.p.A. postpone the final terms of the deal to August 7, 2020. Closing is expected by year end 2020. Sorgenia Sviluppo S.R.L. completed the acquisition of 75% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. (BIT:AGA) for €3.1 million on December 28, 2020. The consideration includes €0.15 for Green Power Marcallese, €0.6 million for the debt owed by Green Power Marcallese to Agatos and assumed €2.3 million remaining creditor of Green Power Marcallese.Is New 90 Day High Low • Nov 28New 90-day high: €1.04The company is up 3.0% from its price of €1.01 on 28 August 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Construction industry, which is up 9.0% over the same period.Reported Earnings • Oct 04First half earnings releasedOver the last 12 months the company has reported total losses of €2.86m, with losses widening by 32% from the prior year. Total revenue was €3.84m over the last 12 months, down 41% from the prior year.株主還元5JS1DE ConstructionDE 市場7D0%-2.2%-3.0%1Y-59.0%176.4%-0.7%株主還元を見る業界別リターン: 5JS1過去 1 年間で176.4 % の収益を上げたGerman Construction業界を下回りました。リターン対市場: 5JS1は、過去 1 年間で-0.7 % のリターンを上げたGerman市場を下回りました。価格変動Is 5JS1's price volatile compared to industry and market?5JS1 volatility5JS1 Average Weekly Movementn/aConstruction Industry Average Movement5.0%Market Average Movement5.9%10% most volatile stocks in DE Market13.2%10% least volatile stocks in DE Market2.7%安定した株価: 5JS1の株価は、 German市場と比較して過去 3 か月間で変動しています。時間の経過による変動: 過去 1 年間の5JS1のボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイトn/a23Massimo Mannoriwww.agatos.itもっと見るAgatos S.p.A. 基礎のまとめAgatos の収益と売上を時価総額と比較するとどうか。5JS1 基礎統計学時価総額€4.87m収益（TTM）-€3.68m売上高(TTM)€20.63m0.2xP/Sレシオ-1.3xPER（株価収益率5JS1 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計5JS1 損益計算書（TTM）収益€20.63m売上原価€20.65m売上総利益-€23.58kその他の費用€3.66m収益-€3.68m直近の収益報告Dec 31, 2022次回決算日該当なし一株当たり利益（EPS）-0.18グロス・マージン-0.11%純利益率-17.87%有利子負債／自己資本比率-500.9%5JS1 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2023/12/26 13:19終値2023/09/28 00:00収益2022/12/31年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Agatos S.p.A. 1 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Arianna TerazziIntesa Sanpaolo Equity ResearchMarco CristoforiIntesa Sanpaolo Equity Research
New Risk • Jul 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-€3.4m). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Market cap is less than US$10m (€8.25m market cap, or US$9.18m). Minor Risk Less than 1 year of cash runway based on current free cash flow (-€7.9m).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Sep 24Agatos S.p.A. announced that it expects to receive €10 million in funding from Macquarie Group Limited, Investment Arm and other investorAgatos S.p.A. announced a private placement of convertible bonds for gross proceeds of up to €10,000,000 on September 22, 2022. The transaction will include participation from Macquarie Group Limited, Investment Arm, and ATLAS CAPITAL. The company has approved partial issuance of first tranche of convertible bond for up to €1,500,000.
Reported Earnings • Jun 18Full year 2021 earnings releasedFull year 2021 results: Net loss: €13.2m (loss widened 247% from FY 2020).
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 06First half 2021 earnings releasedThe company reported a soft first half result with increased losses and weaker control over costs, although revenues improved. First half 2021 results: Revenue: €1.93m (up 17% from 1H 2020). Net loss: €6.82m (loss widened 366% from 1H 2020).
New Risk • Jul 12New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 61% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Negative equity (-€3.4m). Shareholders have been substantially diluted in the past year (61% increase in shares outstanding). Market cap is less than US$10m (€8.25m market cap, or US$9.18m). Minor Risk Less than 1 year of cash runway based on current free cash flow (-€7.9m).
Board Change • Nov 16Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
お知らせ • Sep 24Agatos S.p.A. announced that it expects to receive €10 million in funding from Macquarie Group Limited, Investment Arm and other investorAgatos S.p.A. announced a private placement of convertible bonds for gross proceeds of up to €10,000,000 on September 22, 2022. The transaction will include participation from Macquarie Group Limited, Investment Arm, and ATLAS CAPITAL. The company has approved partial issuance of first tranche of convertible bond for up to €1,500,000.
Reported Earnings • Jun 18Full year 2021 earnings releasedFull year 2021 results: Net loss: €13.2m (loss widened 247% from FY 2020).
Board Change • Apr 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
Reported Earnings • Oct 06First half 2021 earnings releasedThe company reported a soft first half result with increased losses and weaker control over costs, although revenues improved. First half 2021 results: Revenue: €1.93m (up 17% from 1H 2020). Net loss: €6.82m (loss widened 366% from 1H 2020).
Breakeven Date Change • Sep 23Forecast to breakeven in 2022The analyst covering Agatos expects the company to break even for the first time. New forecast suggests the company will make a profit of €1.72m in 2022. Average annual earnings growth of 99% is required to achieve expected profit on schedule.
お知らせ • Dec 30Sorgenia Sviluppo S.R.L. completed the acquisition of 75% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. (BIT:AGA) for €3.1 million.Sorgenia Sviluppo S.R.L. made a binding offer to acquire 80% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. (BIT:AGA) for €2.2 million on October 10, 2019. On December 17, 2020, Sorgenia Sviluppo S.R.L. signed agreement to acquire 75% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. Under the terms, the buyer will pay up to €0.2 million and will take up to 80% of Agatos's claims towards the project for up to €2 million. As of April 21, 2020, Agatos said that more time is needed to complete the transaction amid COVID-19 crisis. As of July 8, 2020, Agatos S.p.A. postpone the final terms of the deal to August 7, 2020. Closing is expected by year end 2020. Sorgenia Sviluppo S.R.L. completed the acquisition of 75% stake in Biomethane "Biosip Plus" Project from Agatos S.p.A. (BIT:AGA) for €3.1 million on December 28, 2020. The consideration includes €0.15 for Green Power Marcallese, €0.6 million for the debt owed by Green Power Marcallese to Agatos and assumed €2.3 million remaining creditor of Green Power Marcallese.
Is New 90 Day High Low • Nov 28New 90-day high: €1.04The company is up 3.0% from its price of €1.01 on 28 August 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Construction industry, which is up 9.0% over the same period.
Reported Earnings • Oct 04First half earnings releasedOver the last 12 months the company has reported total losses of €2.86m, with losses widening by 32% from the prior year. Total revenue was €3.84m over the last 12 months, down 41% from the prior year.
